GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Additional Paid-In Capital

Orchid Pharma (NSE:ORCHPHARMA) Additional Paid-In Capital : ₹0 Mil(As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Additional Paid-In Capital?


Orchid Pharma's annual additional paid-in capital stayed the same from Mar. 2022 (₹4,645 Mil) to Mar. 2023 (₹4,645 Mil) but then declined from Mar. 2023 (₹4,645 Mil) to Mar. 2024 (₹0 Mil).

Orchid Pharma Additional Paid-In Capital Historical Data

The historical data trend for Orchid Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Additional Paid-In Capital Chart

Orchid Pharma Annual Data
Trend Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,644.79 4,644.79 4,644.79 4,644.79 -

Orchid Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,644.79 - - - -

Orchid Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Orchid Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchid Pharma (NSE:ORCHPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Additional Paid-In Capital
Comparable Companies
NSE:RPGLIFE BOM:524164 BOM:512529 BOM:509079 BOM:530549 BOM:532612 BOM:590006 BOM:500288 BOM:500672 BOM:506690 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
524372:India
Address
313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034
Website
http://www.orchidpharma.com
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines